SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-033579
Filing Date
2020-12-11
Accepted
2020-12-11 16:36:14
Documents
1
Period of Report
2020-12-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3966
  Complete submission text file 0000899243-20-033579.txt   5503
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address
Hernday Natasha (Reporting) CIK: 0001780547 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37449 | Film No.: 201383917